KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Other Non-Current Liabilities (2016 - 2026)

ClearPoint Neuro's Other Non-Current Liabilities history spans 9 years, with the latest figure at $489000.0 for Q4 2025.

On a quarterly basis, Other Non-Current Liabilities changed N/A to $489000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $489000.0, a N/A change, with the full-year FY2025 number at $489000.0, changed N/A from a year prior.
Other Non-Current Liabilities hit $489000.0 in Q4 2025 for ClearPoint Neuro, up from $263000.0 in the prior quarter.
Over the last five years, Other Non-Current Liabilities for CLPT hit a ceiling of $489000.0 in Q4 2025 and a floor of $263000.0 in Q3 2025.